Life science company Nanologica has announced that its Chief Financial Officer, Eva Osterman, has decided to leave the firm. She will remain in her current role until August 31 to ensure an orderly transition, according to a press release.

The recruitment process for a successor has been initiated. Osterman has served as CFO since 2017 and played a pivotal role in several key milestones, including the company's listing in 2022.

'After more than 9 years with the company, it is time for me to move on. The company and the team have meant a great deal to me, and I take pride in the journey we have shared. I am convinced that the company is currently in a strong position and well-equipped for continued growth. I will be following its future development with great interest,' said Eva Osterman.